|
$87,315
|
To use privacy-protected administrative tax data to evaluate the long-term effects of previously conducted randomized controlled trials.
|
2020
|
LJAF
|
|
$640,213
|
To provide policymakers and key stakeholders with educational resources and technical assistance to help them better understand and apply evidence to improve policies related to surprise medical billing.
|
2019 - 2021
|
LJAF
|
|
$49,086
|
To convene a workshop of academics, experts and key stakeholders to discuss ways to improve the Food and Drug Administration product approval process.
|
2021 - 2022
|
LJAF
|
|
$300,000
|
To support the O'Neill Institute's Addiction and Public Policy Initiative and its effots to translate substance use disorder research into evidence-based policy and practice.
|
2021 - 2023
|
DAF
|
|
$995,410
|
To support evidence-based decision-making in the implementation of policies related to surprise medical billing.
|
2021 - 2023
|
LJAF
|
|
$250,000
|
To analyze the use and consequences of the Parent PLUS program with a focus on racial and economic inequality.
|
2021 - 2023
|
LJAF
|
|
$396,134
|
To support capacity building in the Office of Evaluation Sciences to advance high-quality randomized controlled trials of federally funded programs.
|
2021 - 2022
|
LJAF
|
|
$500,000
|
To support high-impact litigation challenging the criminalization of poverty as it relates to cash bail and pretrial fines and fees.
|
2020 - 2022
|
LJAF
|
|
$50,000
|
To fund a research study that will quantify the extent to which annual employer-funded pension earnings are inequitably deployed across teachers in schools within large urban districts in five states.
|
2016 - 2017
|
LJAF
|
|
$357,213
|
To support national reform of fines and fees practices through nonpartisan training, support, and public education.
|
2018 - 2020
|
LJAF
|
|
$419,864
|
To help the federal government structure, implement, and evaluate performance-based contracting models.
|
2014 - 2015
|
LJAF
|
|
$625,314
|
To conduct a comprehensive assessment of state laws and policies that act as barriers to evidence-based substance use disorder treatment and disseminate nonpartisan educational resources to key stakeholders.
|
2018 - 2021
|
LJAF
|
|
$288,843
|
To encourage the adoption of effective cost containment strategies in state employee health plans.
|
2020 - 2022
|
LJAF
|
